Ambient Air Pollution Exposure and Adverse Outcomes Among Medicare Beneficiaries With Heart Failure.

air pollution death heart failure hospitalization

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
31 Jul 2024
Historique:
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 31 7 2024
Statut: aheadofprint

Résumé

Exposure to fine particulate matter (<2.5 um, particulate matter with an aerodynamic diameter <2.5 microns [PM In this retrospective cohort study, Medicare patients hospitalized with first HF between 2013 and 2020 were identified from the Medicare Provider Analysis and Review Part A 100% files. Patients were linked with integrated estimates of ambient PM Ambient air pollution is associated with higher risk of adverse events in Medicare beneficiaries with established HF. These associations persist below the National Air Quality Standards (12 μg/m

Sections du résumé

BACKGROUND BACKGROUND
Exposure to fine particulate matter (<2.5 um, particulate matter with an aerodynamic diameter <2.5 microns [PM
METHODS AND RESULTS RESULTS
In this retrospective cohort study, Medicare patients hospitalized with first HF between 2013 and 2020 were identified from the Medicare Provider Analysis and Review Part A 100% files. Patients were linked with integrated estimates of ambient PM
CONCLUSIONS CONCLUSIONS
Ambient air pollution is associated with higher risk of adverse events in Medicare beneficiaries with established HF. These associations persist below the National Air Quality Standards (12 μg/m

Identifiants

pubmed: 39082400
doi: 10.1161/JAHA.123.032902
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e032902

Auteurs

Amgad Mentias (A)

Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation Cleveland OH USA.

Milind Y Desai (MY)

Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation Cleveland OH USA.

Ambarish Pandey (A)

Division of Cardiovascular Medicine University of Texas Southwestern Dallas TX USA.

Issam Motairek (I)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University Cleveland OH USA.

Rohit Moudgil (R)

Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation Cleveland OH USA.

Chonyang Albert (C)

Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation Cleveland OH USA.

Salil V Deo (SV)

Louis Stokes VA Hospital and Case Western Reserve University Cleveland OH USA.

Robert D Brook (RD)

Cardiovascular Prevention Wayne State University and Wayne Health Detroit MI USA.

Venu Menon (V)

Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation Cleveland OH USA.

Sanjay Rajagopalan (S)

Harrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University Cleveland OH USA.

Sadeer Al-Kindi (S)

Center for Health and Nature and the DeBakey Heart and Vascular Center Houston TX USA.

Classifications MeSH